Common and specific genes in ovarian clear cell carcinoma and serous carcinoma by gene expression analysis

被引:2
作者
Cao, Wenjiao [1 ]
Wang, Lihua [1 ]
机构
[1] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Sch Med, China Welf Inst IPMCH, Shanghai 200030, Peoples R China
关键词
Ovarian clear cell carcinoma (CCC); ovarian serous carcinoma (SC); histological subtype; specific genes; gene expression; 2ND PRIMARY TUMORS; POOR-PROGNOSIS; CANCER; PROGRESSION; PROFILES; SURVIVAL; EVENT;
D O I
10.21037/tcr.2018.11.12
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Gene expression profiles differences of clear cell carcinoma (CCC) and serous carcinoma (SC) have been documented, however, these studies usually miss the specific genes changed only in SC or CCC. This study analyzes gene expression profiles of the two histological types and normal ovarian surface epithelium to determine the common and specific genes in these tumors. Methods: The gene expression profiles GSE29450 and GSE36668 were downloaded and analyzed, followed by differentially expressed genes (DEGs) analysis between ovarian cancer and normal samples. Overlap analysis was performed to identify common and specific DEGs in SC and CCC, and then these DEGs were functionally enriched. Subsequently, the protein-protein interaction (PPI) network was constructed on these DEGs and Oncomine analysis was down on select genes. Results: A set of 1,265 DEGs were common to comparisons of each of the two histologic subtypes with normal ovarian surface epithelium, such as ESPL1 and CDC25C, and they were mainly enriched in functions and pathways associated with "chromosome segregation". In addition, 2,971 specific DEGs were identified in the development of ovarian CCC including ribosomes protein genes and other key nodes. Whereas a list of 4,181 DEGs were in SC progression, such as KIT and SYK. Conclusions: The common genes appearing on each ovarian carcinoma subtype's comparison with normal ovarian surface epithelium may benefit to shed light on the common part of molecular mechanisms for ovarian carcinomas pathogenesis. Whereas the specific genes may provide unique targeted therapy for each histological subtype.
引用
收藏
页码:1501 / 1509
页数:9
相关论文
共 50 条
[31]   SERPINB11 Expression Is Associated With Prognosis of High-grade Serous and Clear Cell Carcinoma of the Ovary [J].
Park, Soo Jin ;
Lim, Whasun ;
Mun, Jaehee ;
Paik, Haerin ;
Park, Sunwoo ;
Lim, Hyunji ;
Kim, Junhwan ;
Lee, Eun Ji ;
Yim, Ga Won ;
Lee, Nara ;
Lee, Cheol ;
Kim, Jae-Weon ;
Song, Gwonhwa ;
Kim, Hee Seung .
IN VIVO, 2021, 35 (05) :2647-2653
[32]   The expression analysis of NGAL and NGALR in clear cell renal cell carcinoma [J].
Liu, Feng ;
Li, Na ;
Yang, Wei ;
Wang, Ruifang ;
Yu, Jing ;
Wang, Xiaofeng .
GENE, 2018, 676 :269-278
[33]   Expression and clinical role of chemoresponse-associated genes in ovarian serous carcinoma [J].
Nymoen, Dag Andre ;
Falkenthal, Thea E. Hetland ;
Holth, Arild ;
Ow, Ghim Siong ;
Ivshina, Anna V. ;
Trope, Claes G. ;
Kuznetsov, Vladimir A. ;
Staff, Anne Cathrine ;
Davidson, Ben .
GYNECOLOGIC ONCOLOGY, 2015, 139 (01) :30-39
[34]   Gene expression profiling of clear cell papillary renal cell carcinoma: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma [J].
Fisher, Kevin E. ;
Yin-Goen, Qiqin ;
Alexis, Dianne ;
Sirintrapun, Joseph S. ;
Harrison, William ;
Isett, R. Benjamin ;
Rossi, Michael R. ;
Moreno, Carlos S. ;
Young, Andrew N. ;
Osunkoya, Adeboye O. .
MODERN PATHOLOGY, 2014, 27 (02) :222-230
[35]   Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE) [J].
Talhouk, Aline ;
George, Joshy ;
Wang, Chen ;
Budden, Timothy ;
Tan, Tuan Zea ;
Chiu, Derek S. ;
Kommoss, Stefan ;
Leong, Huei San ;
Chen, Stephanie ;
Intermaggio, Maria P. ;
Gilks, Blake ;
Nazeran, Tayyebeh M. ;
Volchek, Mila ;
Elatre, Wafaa ;
Bentley, Rex C. ;
Senz, Janine ;
Lum, Amy ;
Chow, Veronica ;
Sudderuddin, Hanwei ;
Mackenzie, Robertson ;
Leong, Samuel C. Y. ;
Liu, Geyi ;
Johnson, Dustin ;
Chen, Billy ;
Alsop, Jennifer ;
Banerjee, Susana N. ;
Behrens, Sabine ;
Bodelon, Clara ;
Brand, Alison H. ;
Brinton, Louise ;
Carney, Michael E. ;
Chiew, Yoke-Eng ;
Cushing-Haugen, Kara L. ;
Cybulski, Cezary ;
Ennis, Darren ;
Fereday, Sian ;
Fortner, Renee T. ;
Garcia-Donas, Jesus ;
Gentry-Maharaj, Aleksandra ;
Glasspool, Rosalind ;
Goranova, Teodora ;
Greene, Casey S. ;
Haluska, Paul ;
Harris, Holly R. ;
Hendley, Joy ;
Hernandez, Brenda Y. ;
Herpel, Esther ;
Jimenez-Linan, Mercedes ;
Karpinskyj, Chloe ;
Kaufmann, Scott H. .
CLINICAL CANCER RESEARCH, 2020, 26 (20) :5411-5423
[36]   Comprehensive analysis of LAMC1 expression and prognostic value in kidney renal papillary cell carcinoma and clear cell carcinoma [J].
Bai, Jianrong ;
Zheng, Axiu ;
Ha, Yanping ;
Xu, Xiaoqing ;
Yu, Yaping ;
Lu, Yanda ;
Zheng, Shaojiang ;
Shen, Zhihua ;
Luo, Botao ;
Jie, Wei .
FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
[37]   Role of Inflammatory Related Gene Expression in Clear Cell Renal Cell Carcinoma Development and Clinical Outcomes [J].
Tan, Weiqi ;
Hildebrandt, Michelle A. T. ;
Pu, Xia ;
Huang, Maosheng ;
Lin, Jie ;
Matin, Surena F. ;
Tamboli, Pheroze ;
Wood, Christopher G. ;
Wu, Xifeng .
JOURNAL OF UROLOGY, 2011, 186 (05) :2071-2077
[38]   Expression levels of sonic hedgehog pathway genes and their targets are upregulated in early clear cell renal cell carcinoma [J].
Kotulak-Chrzaszcz, Anna ;
Rybarczyk, Agnieszka ;
Klacz, Jakub ;
Matuszewski, Marcin ;
Kmiec, Zbigniew ;
Wierzbicki, Piotr M. .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2022, 49 (05)
[39]   L1CAM expression associates with poor outcome in endometrioid, but not in clear cell ovarian carcinoma [J].
Soovares, Piret ;
Pasanen, Annukka ;
Butzow, Ralf ;
Lassus, Heini .
GYNECOLOGIC ONCOLOGY, 2017, 146 (03) :615-622
[40]   Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: A meta-analysis [J].
Lee, Yoo-Young ;
Kim, Tae-Joong ;
Kim, Min-Ji ;
Kim, Ha-Jeong ;
Song, Taejong ;
Kim, Min Kyu ;
Choi, Chel Hun ;
Lee, Jeong-Won ;
Bae, Duk-Soo ;
Kim, Byoung-Gie .
GYNECOLOGIC ONCOLOGY, 2011, 122 (03) :541-547